Anthony H Futerman

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Venues

Nature communications

NPJ Parkinson's disease

Journal of neurochemistry

The FEBS journal

Weizmann Institute of Science

Weizmann Institute of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Weizmann Institute of Science

Israel

Head :: Benoziyo Center for Neurological Diseases

Weizmann Institute of Science

Israel

Full Professor :: Biological Chemistry

Weizmann Institute of Science

Israel

Associate Professor :: Biological Chemistry

Weizmann Institute of Science

Israel

Assistant Professor :: Membrane Research and Biphysics

Carnegie Institution for Science

United States

Postdoctoral Fellow

Education History

Weizmann Institute of Science

Israel

PHD :: Neurobiology

Publications

Ivan Milenkovic, Shani Blumenreich, Ariel Hochfelder, Aviya Azulay, Inbal E Biton, Mirie Zerbib, Roni Oren, Michael Tsoory, Tammar Joseph, Sarel J Fleishman, Anthony H Futerman
Efficacy of an AAV vector encoding a thermostable form of glucocerebrosidase in alleviating symptoms in a Gaucher disease mouse model. Gene therapy (2024)
Shani Blumenreich, Tamar Nehushtan, Meital Kupervaser, Tali Shalit, Alexandra Gabashvili, Tammar Joseph, Ivan Milenkovic, John Hardy, Anthony H Futerman
Large-scale proteomics analysis of five brain regions from Parkinson's disease patients with a GBA1 mutation. NPJ Parkinson's disease 10 (1) (2024)
Shani Blumenreich, Tamar Nehushtan, Meital Kupervaser, Tali Shalit, Alexandra Gabashvili, Tammar Joseph, Ivan Milenkovic, John Hardy, Anthony H Futerman
Large-scale proteomics analysis of five brain regions from Parkinson's disease patients with a GBA1 mutation. NPJ Parkinson's disease 10 (1) (2024)
Shani Blumenreich, Tamar Nehushtan, Meital Kupervaser, Tali Shalit, Alexandra Gabashvili, Tammar Joseph, Ivan Milenkovic, John Hardy, Anthony H Futerman
Large-scale proteomics analysis of five brain regions from Parkinson's disease patients with a GBA1 mutation. NPJ Parkinson's disease 10 (1) (2024)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Shani Blumenreich, Doreen Padan Ben-Yashar, Tali Shalit, Meital Kupervaser, Ivan Milenkovic, Tammar Joseph, Anthony H Futerman
Proteomics analysis of the brain from a Gaucher disease mouse identifies pathological pathways including a possible role for transglutaminase 1. Journal of neurochemistry (2023)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Sarka Pokorna, Olga Khersonsky, Rosalie Lipsh-Sokolik, Adi Goldenzweig, Rebekka Nielsen, Yacov Ashani, Yoav Peleg, Tamar Unger, Shira Albeck, Orly Dym, Asa Tirosh, Rana Tarayra, Michaël Hocquemiller, Ralph Laufer, Shifra Ben-Dor, Israel Silman, Joel L Sussman, Sarel Jacob Fleishman, Anthony H Futerman
Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification. The FEBS journal (2023)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Sarka Pokorna, Olga Khersonsky, Rosalie Lipsh-Sokolik, Adi Goldenzweig, Rebekka Nielsen, Yacov Ashani, Yoav Peleg, Tamar Unger, Shira Albeck, Orly Dym, Asa Tirosh, Rana Tarayra, Michaël Hocquemiller, Ralph Laufer, Shifra Ben-Dor, Israel Silman, Joel L Sussman, Sarel J Fleishman, Anthony H Futerman
Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification. The FEBS journal (2023)
Iris D Zelnik, Beatriz Mestre, Jonathan Yaacov Weinstein, Tamir Dingjan, Stav Izrailov, Shifra Ben-Dor, Sarel Jacob Fleishman, Anthony H Futerman
Computational design and molecular dynamics simulations suggest the mode of substrate binding in ceramide synthases. Nature communications 14 (1) (2023)
Tania C B Santos, Tamir Dingjan, Anthony H Futerman
The sphingolipid anteome: implications for evolution of the sphingolipid metabolic pathway. FEBS letters 596 (18) (2022)
Jiyoon Kim, Yael Pewzner-Jung, Tammar Joseph, Shifra Ben-Dor, Anthony H Futerman
Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif. PloS one 17 (7) (2022)
Shani Blumenreich, Tamar Nehushtan, Or B Barav, Jennifer T Saville, Tamir Dingjan, John Hardy, Maria Fuller, Anthony H Futerman
Elevation of gangliosides in four brain regions from Parkinson's disease patients with a GBA mutation. NPJ Parkinson's disease 8 (1) (2022)
Iris D Zelnik, Jiyoon L Kim, Anthony H Futerman
The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease. Journal of lipid and atherosclerosis 10 (3) (2021)
Ayelet Vardi, Amir Pri-Or, Noa Wigoda, Yulia Grishchuk, Anthony H Futerman
Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways. Orphanet journal of rare diseases 16 (1) (2021)
Shani Blumenreich, Chen Yaacobi, Ayelet Vardi, Or B Barav, Einat B Vitner, Hyejung Park, Bing Wang, Seng H Cheng, Sergio P Sardi, Anthony H Futerman
Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease. Journal of neurochemistry 156 (5) (2020)
Shani Blumenreich, Bethan J Jenkins, Or B Barav, Ivan Milenkovic, Anthony H Futerman
The Lysosome and Nonmotor Symptoms: Linking Parkinson's Disease and Lysosomal Storage Disorders. Movement disorders : official journal of the Movement Disorder Society 35 (12) (2020)
Iris D Zelnik, Giora Volpert, Leena E Viiri, Dimple Kauhanen, Tamar Arazi, Katriina Aalto-Setälä, Reijo Laaksonen, Anthony H Futerman
Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids. Journal of lipid research 61 (10) (2020)
Ayelet Vardi, Shifra Ben-Dor, Soo Min Cho, Ulrich Kalinke, Julia Spanier, Anthony H Futerman
Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease. Journal of neuroinflammation 17 (1) (2020)
Soo Min Cho, Ayelet Vardi, Nicolas Platt, Anthony H Futerman
Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders. Journal of neurochemistry 148 (5) (2018)
Giora Volpert, Shifra Ben-Dor, Ohad Tarcic, Jingjing Duan, Ann Saada, Alfred H Merrill, Yael Pewzner-Jung, Anthony H Futerman
Oxidative stress elicited by modifying the ceramide acyl chain length reduces the rate of clathrin-mediated endocytosis. Journal of cell science 130 (8) (2017)

Anthony H Futerman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anthony H Futerman